| Literature DB >> 26396690 |
Curt A Dvorak1, Heather Coate1, Diane Nepomuceno1, Michelle Wennerholm1, Chester Kuei1, Brian Lord1, David Woody1, Pascal Bonaventure1, Changlu Liu1, Timothy Lovenberg1, Nicholas I Carruthers1.
Abstract
A focused high throughput screening for GPR139 was completed for a select 100K compounds, and new agonist leads were identified. Subsequent analysis and structure-activity relationship studies identified (S)-3-chloro-N-(2-oxo-2-((1-phenylethyl)amino)ethyl)benzamide 7c as a potent and selective agonist of hGPR139 with an EC50 = 16 nM. The compound was found to cross the blood-brain barrier and have good drug-like properties amenable for oral dosing in rat.Entities:
Keywords: GPR139; Orphan receptors; agonists; glycine amides
Year: 2015 PMID: 26396690 PMCID: PMC4569879 DOI: 10.1021/acsmedchemlett.5b00247
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345